« Return to News | Awards & Advancement

ICON named clinical research team of the year

Monday, November 7, 2011 10:10 AM

ICON has won the clinical research team of the year award at the annual 2011 Scrip Awards.

ICON won the award for a project involving the unexpected, rapid closure of selective populations participating in a mega trial program consisting of over 19,000 subjects at approximately 900 sites world-wide. The close-out was achieved initially by careful consideration of the regulatory and ethics considerations relating to the closure and subsequently by the careful planning and coordination of activities that were required to achieve a complete and appropriate closure.

“We are delighted with the award from Scrip and that our team has been recognized as the industry’s best. The unexpected closure of selective populations in a mega-trial program is a highly unusual situation which demanded a clear understanding of the regulatory and ethics considerations, a detailed and achievable plan, excellent communication, good leadership and a dedicated, hardworking team. Our team performed this complex task exceptionally and it’s nice to see that their efforts have been recognized," said Ciaran Murray, CEO, ICON.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.